Constantine Alifrangis

1.6k total citations
49 papers, 741 citations indexed

About

Constantine Alifrangis is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Constantine Alifrangis has authored 49 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Constantine Alifrangis's work include Testicular diseases and treatments (15 papers), Genital Health and Disease (11 papers) and Urologic and reproductive health conditions (10 papers). Constantine Alifrangis is often cited by papers focused on Testicular diseases and treatments (15 papers), Genital Health and Disease (11 papers) and Urologic and reproductive health conditions (10 papers). Constantine Alifrangis collaborates with scholars based in United Kingdom, Netherlands and Australia. Constantine Alifrangis's co-authors include Mark Linch, Thomas Powles, Alex Freeman, Ursula McGovern, Michael J. Seckl, Rosemary A. Fisher, Delia Short, Richard J. Harvey, Roshan Agarwal and Neil J. Sebire and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Genetics.

In The Last Decade

Constantine Alifrangis

46 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Constantine Alifrangis United Kingdom 10 277 268 163 162 130 49 741
Alexandra Sebastianelli Canada 21 333 1.2× 135 0.5× 54 0.3× 102 0.6× 178 1.4× 42 1.1k
Tim Svenstrup Poulsen Denmark 17 324 1.2× 66 0.2× 137 0.8× 114 0.7× 323 2.5× 71 896
Christian Flotho Germany 23 974 3.5× 38 0.1× 242 1.5× 60 0.4× 108 0.8× 62 1.6k
Chimene Kesserwan United States 14 240 0.9× 29 0.1× 77 0.5× 92 0.6× 179 1.4× 24 661
Nirupa Murugaesu United Kingdom 10 277 1.0× 208 0.8× 53 0.3× 98 0.6× 185 1.4× 16 648
Angela George United Kingdom 17 412 1.5× 54 0.2× 81 0.5× 122 0.8× 564 4.3× 60 1.2k
Katie Beierl United States 15 167 0.6× 120 0.4× 222 1.4× 135 0.8× 241 1.9× 24 683
Yoshihiro Nishioka Japan 15 279 1.0× 56 0.2× 40 0.2× 63 0.4× 156 1.2× 29 752
Joan Murphy Canada 16 281 1.0× 127 0.5× 79 0.5× 67 0.4× 162 1.2× 22 910
Tina Mayer United States 12 308 1.1× 103 0.4× 22 0.1× 323 2.0× 321 2.5× 64 881

Countries citing papers authored by Constantine Alifrangis

Since Specialization
Citations

This map shows the geographic impact of Constantine Alifrangis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantine Alifrangis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantine Alifrangis more than expected).

Fields of papers citing papers by Constantine Alifrangis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantine Alifrangis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantine Alifrangis. The network helps show where Constantine Alifrangis may publish in the future.

Co-authorship network of co-authors of Constantine Alifrangis

This figure shows the co-authorship network connecting the top 25 collaborators of Constantine Alifrangis. A scholar is included among the top collaborators of Constantine Alifrangis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantine Alifrangis. Constantine Alifrangis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bandini, Marco, Éva Compérat, Gert De Meerleer, et al.. (2024). Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open. 9(7). 103481–103481. 6 indexed citations
2.
Pang, Karl H., Giuseppe Fallara, Akash Ghosh, et al.. (2024). Long-term outcomes of penile squamous cell carcinoma in men age ≤50 years old compared with men >50 years old from a single tertiary referral centre: a propensity score matched analysis. International Journal of Impotence Research. 37(9). 771–777. 1 indexed citations
3.
Arora, Rupali, Daniel M. Berney, Constantine Alifrangis, et al.. (2023). Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy. Frontiers in Oncology. 13. 1271647–1271647. 2 indexed citations
4.
Leone, Gianmarco & Constantine Alifrangis. (2023). New developments in the management of newly diagnosed metastatic prostate cancer. Trends in Urology & Men s Health. 14(3). 6–9.
5.
Lloyd, Paul, Anne Hong, Marc A. Furrer, et al.. (2021). A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections. World Journal of Urology. 40(1). 119–126. 22 indexed citations
6.
Alifrangis, Constantine, Olivia Lucas, Sarah Benafif, et al.. (2020). Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery. European Urology Focus. 7(4). 835–842. 7 indexed citations
7.
Scandura, Glenda, Thomas Wagner, Luis Beltrán, et al.. (2020). Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?. Modern Pathology. 34(4). 834–841. 3 indexed citations
8.
Alifrangis, Constantine, Alvin Lee, Sanjay K. Fernando, et al.. (2020). 784P Perioperative multimodality treatment in high-risk node-positive penile cancer: A single institution study of patients treated in a supraregional centre. Annals of Oncology. 31. S599–S599. 1 indexed citations
9.
Alifrangis, Constantine, Anand Sharma, Andrew Gogbashian, et al.. (2020). Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients. European Journal of Cancer. 164. 105–113. 16 indexed citations
10.
Ng, Kenrick, Ursula McGovern, Myria Galazi, et al.. (2020). Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxis. Prostate Cancer and Prostatic Diseases. 24(1). 166–168. 1 indexed citations
11.
Sharma, Anand, Constantine Alifrangis, Marcia Hall, et al.. (2019). Somatic Transformation in Metastatic Testicular Germ Cell Tumours – A Different Disease Entity. Anticancer Research. 39(9). 4911–4916. 8 indexed citations
12.
Smith, Katherine, Myria Galazi, Mark R. Openshaw, et al.. (2019). The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. Clinical Genitourinary Cancer. 18(3). e217–e223. 3 indexed citations
13.
Scandura, Glenda, Thomas Wagner, Luis Beltrán, et al.. (2019). Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition. Human Pathology. 94. 16–22. 9 indexed citations
14.
Quispel-Janssen, Josine M.M.F., Yongsoo Kim, Constantine Alifrangis, et al.. (2017). Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses. Clinical Cancer Research. 24(7). 1761–1770. 9 indexed citations
15.
Quispel-Janssen, Josine M.M.F., Jitendra Badhai, Stacey Price, et al.. (2017). Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition. Clinical Cancer Research. 24(1). 84–94. 32 indexed citations
16.
Alifrangis, Constantine & Ultan McDermott. (2014). Reading between the lines; understanding drug response in the post genomic era. Molecular Oncology. 8(6). 1112–1119. 11 indexed citations
17.
Wong, Chi Chun, Sancha Martin, Alistair G. Rust, et al.. (2013). Inactivating CUX1 mutations promote tumorigenesis. Nature Genetics. 46(1). 33–38. 96 indexed citations
18.
Alifrangis, Constantine, et al.. (2011). New drugs for prostate cancer. British Journal of Urology. 109(12). 1801–1806. 4 indexed citations
19.
Alifrangis, Constantine, Rebecca Evans, Janet K. Williams, & MJ Seckl. (2011). An unusual gum lesion with a positive pregnancy test. BMJ. 343(aug11 2). d5009–d5009. 3 indexed citations
20.
Alifrangis, Constantine, Jonny Harcourt, Ondřej Gojiš, & Carlo Palmieri. (2009). Poor reception?. The Lancet. 374(9693). 948–948. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Sebastianelli Breakdown of academic impact, for papers by Tim Svenstrup Poulsen Breakdown of academic impact, for papers by Christian Flotho Breakdown of academic impact, for papers by Chimene Kesserwan Breakdown of academic impact, for papers by Nirupa Murugaesu Breakdown of academic impact, for papers by Angela George Breakdown of academic impact, for papers by Katie Beierl Breakdown of academic impact, for papers by Yoshihiro Nishioka Breakdown of academic impact, for papers by Joan Murphy Breakdown of academic impact, for papers by Tina Mayer
Rankless by CCL
2026